Related Experiment Video
Updated: Apr 24, 2026
Visualization of Mitochondrial DNA Replication in Individual Cells by EdU Signal Amplification
Published on: November 15, 2010
Evaluation of unmodified human cell-derived extracellular vesicle mitochondrial deoxyribonucleic acid-based
Young-Woo Cho1,2, Mi Young Cho3, Jaehyeon Yoon1
1Division of Drug Safety Evaluation, NDDC, Osong Medical Innovation Foundation, Cheongju, South Korea.
Abstract:
Recently, extracellular vesicles (EVs) have been developed as therapeutic targets for various diseases. Biodistribution is crucial for EVs intended for therapeutic purposes because it can determine the degree of on- and off-target effects. This study aimed to explore techniques to evaluate the biodistribution of unmodified EVs. We devised a novel quantitative polymerase chain reaction (qPCR)-based assay to detect unmodified EVs by targeting mitochondrial deoxyribonucleic acid (mtDNA), a constituent of EVs. We focused on specific mtDNA regions that exhibited homologous variations distinct from their rodent mtDNA counterparts to establish this analytical approach. Herein, we successfully designed primers and probes targeting human and rodent mtDNA sequences and developed a highly specific and sensitive qPCR method. Furthermore, the quantification range of EVs isolated from various cells differed based on the manufacturer and cell source. IRDye 800CW-labelled Expi293F EV mimetics were administered to the animals via the tail vein to compare the imaging test and mtDNA-qPCR results. The results obtained from imaging tests and mtDNA-qPCR to investigate EV biodistribution patterns revealed differences. The results revealed that our newly developed method effectively determined the biodistribution of unmodified EVs with high sensitivity and reproducibility.
Insights
Researchers developed a new qPCR assay to track unmodified extracellular vesicles (EVs) using mitochondrial DNA (mtDNA). This method offers a sensitive and reproducible way to study EV biodistribution for therapeutic applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Nanomedicine
Background:
- Extracellular vesicles (EVs) show therapeutic potential for various diseases.
- Accurate biodistribution assessment is critical for evaluating on- and off-target effects of therapeutic EVs.
- Existing methods may have limitations in tracking unmodified EVs.
Purpose of the Study:
- To develop and validate a novel method for evaluating the biodistribution of unmodified extracellular vesicles (EVs).
- To establish a sensitive and reproducible assay for tracking EV biodistribution in vivo.
Main Methods:
- Development of a quantitative polymerase chain reaction (qPCR)-based assay targeting mitochondrial DNA (mtDNA) specific to human or rodent sequences.
- Design of primers and probes for highly specific detection of human and rodent mtDNA within EVs.
- Comparison of biodistribution results obtained from the novel mtDNA-qPCR assay with in vivo imaging techniques.
Main Results:
- A highly specific and sensitive qPCR method for detecting unmodified EVs by targeting mtDNA was successfully established.
- Quantification ranges for EVs varied depending on the manufacturer and cell source.
- The mtDNA-qPCR assay provided distinct biodistribution patterns compared to imaging tests, highlighting its unique capabilities.
Conclusions:
- The newly developed mtDNA-qPCR assay is an effective tool for determining the biodistribution of unmodified EVs.
- This method offers high sensitivity and reproducibility, crucial for advancing EV-based therapeutics.
- The assay provides a valuable approach for preclinical evaluation of EV delivery and targeting.
